MEDICAL RESEARCH AND GENETIC RESOURCES MANAGEMENT: THE CASE OF TAXOL
Commercial development of the anti-cancer drug taxol has involved a complex set of interlocking research agreements. This paper explores the implications of such agreements and discusses diverse policy issues surrounding taxol development. Among these are forest management, species preservation, intellectual property rights, and the economics of biomedical research. Advances in genetic research increasingly have linked natural resource and technology policy issues. Institutional innovations in public/private research arrangements play a vital role in biotechnology development but are poorly understood. Policymakers need formal analyses of such agreements in order to evaluate complex research programs. Copyright 1993 Western Economic Association International.
Year of publication: |
1993
|
---|---|
Authors: | Day, KELLY A. ; Frisvold, GEORGE B. |
Published in: |
Contemporary Economic Policy. - Western Economic Association International - WEAI, ISSN 1074-3529. - Vol. 11.1993, 3, p. 1-11
|
Publisher: |
Western Economic Association International - WEAI |
Saved in:
freely available
Saved in favorites
Similar items by person
-
Medical Research and Genetic Resources Management: The Case of Taxol
Day, Kelly A., (1993)
-
THE DEFICIT IN NATURAL RESOURCE RESEARCH
Day, Kelly A., (1989)
-
Chapter 18: MEASURING THE FOOD SAFETY RISK OF PESTICIDES
Day, Kelly A.,
- More ...